Infectolab Americas LLC v. ArminLabs GmbH

Good Law
United States District Court, Northern District of CaliforniaJanuary 28, 20215:20-cv-03318California4,343 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 7 INFECTOLAB AMERICAS LLC, et al., Case No. 20-cv-03318-VKD

Plaintiffs, ORDER GRANTING DEFENDANT'S v. MOTION TO DISMISS FIRST

AMENDED COMPLAINT

ARMINLABS GmbH, Re: Dkt. No. 22 Defendant.

13 Plaintiffs Infectolab Americas LLC (“Infectolab”) and IGeneX, Inc. (“IGeneX”) filed this action alleging violation of the Lanham Act, 41 U.S.C. § 1125(a)(1), and asserting several state law claims for relief. Pursuant to stipulation (Dkt. No. 19), plaintiffs filed a First Amended Complaint (“FAC”), the operative pleading (Dkt. No. 20). Defendant ArminLabs GmbH (“ArminLabs”) now moves pursuant to Rule 12(b)(6) to dismiss three claims asserted only by Infectolab for intentional and negligent interference with prospective economic advantage and tortious interference with contract. Infectolab concedes the motion with respect to its claim for negligent interference with prospective economic advantage, but…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.